| Year |
Citation |
Score |
| 2022 |
Bart G, Jaber M, Giang LM, Brundage RC, Korthuis PT. Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability. Drug and Alcohol Dependence. 241: 109696. PMID 36402052 DOI: 10.1016/j.drugalcdep.2022.109696 |
0.625 |
|
| 2021 |
Bart G, Giang LM, Yen H, Hodges JS, Brundage RC. Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study. Drug and Alcohol Dependence. 227: 109025. PMID 34482033 DOI: 10.1016/j.drugalcdep.2021.109025 |
0.611 |
|
| 2020 |
Al-Rayess H, Fleissner K, Jaber M, Brundage RC, Sarafoglou K. Manipulation of Hydrocortisone Tablets Leads to Iatrogenic Cushing Syndrome in a 6-Year-Old Girl With CAH. Journal of the Endocrine Society. 4: bvaa091. PMID 32803093 DOI: 10.1210/Jendso/Bvaa091 |
0.331 |
|
| 2020 |
Basu C, Ma X, Mo M, Xia HA, Brundage R, Al-Kofahi M, Carlin BP. Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidism. Pharmaceutical Statistics. PMID 32648333 DOI: 10.1002/Pst.2043 |
0.364 |
|
| 2020 |
Alhadab AA, Brundage RC. Population Pharmacokinetics of Sertraline in Healthy Subjects: a Model-Based Meta-analysis. The Aaps Journal. 22: 73. PMID 32430638 DOI: 10.1208/S12248-020-00455-Y |
0.415 |
|
| 2020 |
Alhadab AA, Brundage RC. Physiologically-Based Pharmacokinetic Model of Sertraline in Human to Predict Clinical Relevance of Concentrations at Target Tissues. Clinical Pharmacology and Therapeutics. PMID 32128758 DOI: 10.1002/Cpt.1824 |
0.387 |
|
| 2019 |
Alhadab AA, Rhein J, Tugume L, Musubire A, Williams DA, Abassi M, Nicol MR, Meya DB, Boulware DR, Brundage RC. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis. Journal of Pharmacokinetics and Pharmacodynamics. PMID 31584146 DOI: 10.1007/S10928-019-09657-0 |
0.436 |
|
| 2019 |
Ahmed MA, Okour M, Brundage R, Kartha RV. Orphan drug development: the increasing role of clinical pharmacology. Journal of Pharmacokinetics and Pharmacodynamics. PMID 31338634 DOI: 10.1007/S10928-019-09646-3 |
0.303 |
|
| 2018 |
Okour M, Brundage RC. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies. European Journal of Drug Metabolism and Pharmacokinetics. PMID 30488336 DOI: 10.1007/S13318-018-0535-1 |
0.333 |
|
| 2018 |
Ahn JE, Bathena SPR, Brundage RC, Conway JM, Leppik IE, Birnbaum AK. Iron supplements in nursing home patients associated with reduced carbamazepine absorption. Epilepsy Research. 147: 115-118. PMID 30327119 DOI: 10.1016/J.Eplepsyres.2018.07.015 |
0.613 |
|
| 2018 |
Polepally AR, Brundage RC, Remmel RP, Leppik IE, Pennell PB, White JR, Ramsay RE, Kistner BM, Birnbaum AK. Lamotrigine pharmacokinetics following oral and stable-labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age. Epilepsia. PMID 30101556 DOI: 10.1111/Epi.14519 |
0.334 |
|
| 2018 |
Alhadab AA, Ahmed MA, Brundage RC. Amikacin Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis in Pediatric Cancer Patients. Antimicrobial Agents and Chemotherapy. PMID 29358293 DOI: 10.1128/Aac.01781-17 |
0.386 |
|
| 2018 |
Okour M, Jacobson PA, Ahmed MA, Israni AK, Brundage RC. Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure. Journal of Clinical Pharmacology. PMID 29329489 DOI: 10.1002/Jcph.1064 |
0.36 |
|
| 2017 |
Ahmed GF, Bathena SP, Brundage RC, Leppik IE, Conway JM, Schwartz JB, Birnbaum AK. Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients. The Aaps Journal. PMID 28070716 DOI: 10.1208/S12248-016-0022-Z |
0.342 |
|
| 2017 |
Okour M, Brundage RC. Modeling Enterohepatic Circulation Current Pharmacology Reports. 3: 301-313. DOI: 10.1007/S40495-017-0096-Z |
0.346 |
|
| 2016 |
Basu C, Ahmed MA, Kartha RV, Brundage RC, Raymond GV, Cloyd JC, Carlin BP. A Hierarchical Bayesian Approach for Combining Pharmacokinetic/Pharmacodynamic Modeling and Phase IIa Trial Design in Orphan Drugs: Treating Adrenoleukodystrophy with Lorenzo's Oil. Journal of Biopharmaceutical Statistics. PMID 27547896 DOI: 10.1080/10543406.2016.1226326 |
0.39 |
|
| 2016 |
Flora DR, Rettie AE, Brundage RC, Tracy TS. CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites. Journal of Clinical Pharmacology. PMID 27539372 DOI: 10.1002/Jcph.813 |
0.309 |
|
| 2016 |
Johnson KH, Webb CH, Schmeling DO, Brundage RC, Balfour HH. Epstein-Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study. Clinical & Translational Immunology. 5: e81. PMID 27350880 DOI: 10.1038/Cti.2016.28 |
0.307 |
|
| 2016 |
Sanghavi K, Wiseman A, Kirstein MN, Cao Q, Brundage R, Jensen K, Rogosheske J, Kurtzweil A, Long-Boyle J, Wagner J, Warlick ED, Brunstein CG, Weisdorf DJ, Jacobson PA. Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 27094990 DOI: 10.1016/J.Trsl.2016.03.017 |
0.363 |
|
| 2016 |
Garnett C, Needleman K, Liu J, Brundage R, Wang Y. Operational Characteristics of Linear Concentration-QT Models for Assessing QTc Interval in the Thorough QT and Phase 1 Clinical Studies. Clinical Pharmacology and Therapeutics. PMID 26946218 DOI: 10.1002/Cpt.361 |
0.676 |
|
| 2015 |
Sanghavi K, Brundage RC, Miller MB, Schladt DP, Israni AK, Guan W, Oetting WS, Mannon RB, Remmel RP, Matas AJ, Jacobson PA. Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. The Pharmacogenomics Journal. PMID 26667830 DOI: 10.1038/Tpj.2015.87 |
0.336 |
|
| 2015 |
Lim CN, Birnbaum AK, Brundage RC, Leppik IE, Cloyd JC, Clark A, Marino SE. Pharmacokinetic-pharmacodynamic modeling of intravenous and oral topiramate and its effect on the symbol digit modalities test in adult healthy volunteers. Journal of Clinical Pharmacology. PMID 26395889 DOI: 10.1002/Jcph.646 |
0.437 |
|
| 2015 |
Polepally AR, Remmel RP, Brundage RC, Leppik IE, Rarick JO, Ramsay RE, Birnbaum AK. Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology. Journal of Clinical Pharmacology. 55: 1101-8. PMID 25903807 DOI: 10.1002/Jcph.522 |
0.351 |
|
| 2015 |
Ahmed GF, Marino SE, Brundage RC, Pakhomov SV, Leppik IE, Cloyd JC, Clark A, Birnbaum AK. Pharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers. British Journal of Clinical Pharmacology. 79: 820-30. PMID 25403343 DOI: 10.1111/Bcp.12556 |
0.361 |
|
| 2015 |
Sarafoglou K, Gonzalez-Bolanos MT, Zimmerman CL, Boonstra T, Yaw Addo O, Brundage R. Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets. Journal of Clinical Pharmacology. 55: 452-7. PMID 25385533 DOI: 10.1002/Jcph.424 |
0.362 |
|
| 2014 |
Bart G, Lenz S, Straka RJ, Brundage RC. Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study. Drug and Alcohol Dependence. 145: 185-93. PMID 25456329 DOI: 10.1016/J.Drugalcdep.2014.10.014 |
0.646 |
|
| 2014 |
Vezina HE, Brundage RC, Balfour HH. Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients. British Journal of Clinical Pharmacology. 78: 343-52. PMID 24528138 DOI: 10.1111/Bcp.12343 |
0.726 |
|
| 2014 |
Khatri A, Williams BW, Fisher J, Brundage RC, Gurvich VJ, Lis LG, Skubitz KM, Dudek AZ, Greeno EW, Kratzke RA, Lamba JK, Kirstein MN. SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours. British Journal of Cancer. 110: 304-12. PMID 24300978 DOI: 10.1038/Bjc.2013.738 |
0.619 |
|
| 2014 |
Salem AH, Fletcher CV, Brundage RC. Pharmacometric characterization of efavirenz developmental pharmacokinetics and pharmacogenetics in HIV-infected children. Antimicrobial Agents and Chemotherapy. 58: 136-43. PMID 24145522 DOI: 10.1128/Aac.01738-13 |
0.549 |
|
| 2014 |
Wang T, Baron K, Zhong W, Brundage R, Elmquist W. Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design. Pharmaceutical Research. 31: 649-59. PMID 24092052 DOI: 10.1007/S11095-013-1187-0 |
0.748 |
|
| 2014 |
Sanghavi K, Wiseman AC, Cao Q, Warlick ED, Brunstein CG, Brundage R, Rogosheske J, Kurtzweil A, Wagner JE, Weisdorf DJ, Jacobson PA. Pharmacokinetic Modeling of Fludarabine to Control Exposure and Improve Outcomes after Reduced Intensity Conditioning Transplantation Blood. 124: 3869-3869. DOI: 10.1182/Blood.V124.21.3869.3869 |
0.389 |
|
| 2014 |
Sanghavi K, Wiseman AC, Kirstein M, Brundage R, Jacobson PA. Phosphoramide Mustard (PM) Population Pharmacokinetics to Estimate Inter-Individual Variability in Exposure and Identify Clinical Factors Associated with Variability in Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HCT) Patients Blood. 124: 2478-2478. DOI: 10.1182/Blood.V124.21.2478.2478 |
0.417 |
|
| 2013 |
Clark AM, Kriel RL, Leppik IE, White JR, Henry TR, Brundage RC, Cloyd JC. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate. Epilepsia. 54: 1106-11. PMID 23586686 DOI: 10.1111/Epi.12165 |
0.404 |
|
| 2013 |
Agarwal SK, Kriel RL, Brundage RC, Ivaturi VD, Cloyd JC. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Epilepsy Research. 105: 362-7. PMID 23561287 DOI: 10.1016/J.Eplepsyres.2013.02.018 |
0.585 |
|
| 2013 |
Clark AM, Kriel RL, Leppik IE, Marino SE, Mishra U, Brundage RC, Cloyd JC. Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers. Epilepsia. 54: 1099-105. PMID 23506041 DOI: 10.1111/Epi.12134 |
0.393 |
|
| 2013 |
Ahmed GF, Brundage RC, Marino SE, Cloyd JC, Leppik IE, Pennell PB, Ramsay RE, Birnbaum AK. Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy. Journal of Clinical Pharmacology. 53: 276-84. PMID 23408495 DOI: 10.1002/Jcph.8 |
0.436 |
|
| 2013 |
Milán Segovia RC, Domínguez Ramírez AM, Jung Cook H, Magaña Aquino M, Vigna Pérez M, Brundage RC, Romano Moreno S. Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis Journal of Clinical Pharmacy and Therapeutics. 38: 56-61. PMID 23167603 DOI: 10.1111/Jcpt.12016 |
0.392 |
|
| 2012 |
Ivaturi V, Kriel R, Brundage R, Loewen G, Mansbach H, Cloyd J. Bioavailability of intranasal vs. rectal diazepam. Epilepsy Research. 103: 254-61. PMID 22981338 DOI: 10.1016/J.Eplepsyres.2012.07.018 |
0.382 |
|
| 2012 |
Punyawudho B, Ramsay ER, Brundage RC, Macias FM, Collins JF, Birnbaum AK. Population pharmacokinetics of carbamazepine in elderly patients. Therapeutic Drug Monitoring. 34: 176-81. PMID 22406657 DOI: 10.1097/Ftd.0B013E31824D6A4E |
0.343 |
|
| 2012 |
Marino SE, Birnbaum AK, Leppik IE, Conway JM, Musib LC, Brundage RC, Ramsay RE, Pennell PB, White JR, Gross CR, Rarick JO, Mishra U, Cloyd JC. Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. Clinical Pharmacology and Therapeutics. 91: 483-8. PMID 22278332 DOI: 10.1038/Clpt.2011.251 |
0.399 |
|
| 2012 |
Kim H, Long-Boyle J, Rydholm N, Orchard PJ, Tolar J, Smith AR, Jacobson P, Brundage R. Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation. Journal of Clinical Pharmacology. 52: 1665-75. PMID 22110162 DOI: 10.1177/0091270011422814 |
0.56 |
|
| 2012 |
Khatri A, Brundage RC, Hull JM, Williams BW, Yee D, Kirstein MN. Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabine. The Aaps Journal. 14: 1-9. PMID 22101930 DOI: 10.1208/S12248-011-9308-3 |
0.538 |
|
| 2011 |
Kiser JJ, Rutstein RM, Samson P, Graham B, Aldrovandi G, Mofenson LM, Smith E, Schnittman S, Fenton T, Brundage RC, Fletcher CV. Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. Aids (London, England). 25: 1489-96. PMID 21610486 DOI: 10.1097/Qad.0B013E328348Fc41 |
0.353 |
|
| 2011 |
Aliwarga T, Cloyd JC, Goel V, Brundage RC, Marino SE, Leppik IE, Remmel RP. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy. Therapeutic Drug Monitoring. 33: 56-63. PMID 21233690 DOI: 10.1097/Ftd.0B013E3182081089 |
0.589 |
|
| 2011 |
Florian JA, Tornøe CW, Brundage R, Parekh A, Garnett CE. Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies. Journal of Clinical Pharmacology. 51: 1152-62. PMID 21228407 DOI: 10.1177/0091270010381498 |
0.406 |
|
| 2011 |
Khatri A, Gaber MW, Brundage RC, Naimark MD, Hanna SK, Stewart CF, Kirstein MN. Effect of radiation on the penetration of irinotecan in rat cerebrospinal fluid. Cancer Chemotherapy and Pharmacology. 68: 721-31. PMID 21161529 DOI: 10.1007/S00280-010-1542-3 |
0.565 |
|
| 2011 |
Kolesar J, Brundage RC, Pomplun M, Alberti D, Holen K, Traynor A, Ivy P, Wilding G. Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients. Cancer Chemotherapy and Pharmacology. 67: 393-400. PMID 20440618 DOI: 10.1007/S00280-010-1331-Z |
0.327 |
|
| 2010 |
Vezina HE, Brundage RC, Nevins TE, Balfour HH. The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus disease. Clinical Pharmacology : Advances and Applications. 2: 1-7. PMID 22291482 DOI: 10.2147/CPAA.S8341 |
0.737 |
|
| 2010 |
Kiser JJ, Bumpass JB, Meditz AL, Anderson PL, Bushman L, Ray M, Predhomme JA, Rower J, MaWhinney S, Brundage R. Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers Antimicrobial Agents and Chemotherapy. 54: 4999-5003. PMID 20921313 DOI: 10.1128/Aac.00636-10 |
0.376 |
|
| 2010 |
Vezina HE, Balfour HH, Weller DR, Anderson BJ, Brundage RC. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis. Journal of Clinical Pharmacology. 50: 734-42. PMID 19897764 DOI: 10.1177/0091270009351884 |
0.749 |
|
| 2008 |
Johnson L, Orchard PJ, Baker KS, Brundage R, Cao Q, Wang X, Langer E, Farag-El Maasah S, Ross JA, Remmel R, Jacobson PA. Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation. Journal of Clinical Pharmacology. 48: 1052-62. PMID 18635758 DOI: 10.1177/0091270008321940 |
0.374 |
|
| 2008 |
Ahn JE, Cloyd JC, Brundage RC, Marino SE, Conway JM, Ramsay RE, White JR, Musib LC, Rarick JO, Birnbaum AK, Leppik IE. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy. Neurology. 71: 38-43. PMID 18591503 DOI: 10.1212/01.Wnl.0000316392.55784.57 |
0.688 |
|
| 2008 |
Kumar V, Brundage RC, Oetting WS, Leppik IE, Tracy TS. Differential genotype dependent inhibition of CYP2C9 in humans. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1242-8. PMID 18378563 DOI: 10.1124/Dmd.108.020396 |
0.347 |
|
| 2008 |
Punyawudho B, Ramsay RE, Macias FM, Rowan AJ, Collins JF, Brundage RC, Birnbaum AK. Population pharmacokinetics of lamotrigine in elderly patients. Journal of Clinical Pharmacology. 48: 455-63. PMID 18296554 DOI: 10.1177/0091270007313391 |
0.401 |
|
| 2008 |
Byon W, Fletcher CV, Brundage RC. Impact of censoring data below an arbitrary quantification limit on structural model misspecification. Journal of Pharmacokinetics and Pharmacodynamics. 35: 101-16. PMID 17963024 DOI: 10.1007/S10928-007-9078-9 |
0.713 |
|
| 2008 |
Fletcher CV, Brundage RC, Fenton T, Alvero CG, Powell C, Mofenson LM, Spector SA. Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial Clinical Pharmacology and Therapeutics. 83: 300-306. PMID 17609682 DOI: 10.1038/Sj.Clpt.6100282 |
0.349 |
|
| 2007 |
Birnbaum AK, Ahn JE, Brundage RC, Hardie NA, Conway JM, Leppik IE. Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents. Therapeutic Drug Monitoring. 29: 571-5. PMID 17898646 DOI: 10.1097/Ftd.0B013E31811F3296 |
0.665 |
|
| 2007 |
Huang J, Jacobson PA, Brundage R. Prediction of unbound mycophenolic acid concentrations in patients after hematopoietic cell transplantation. Therapeutic Drug Monitoring. 29: 385-390. PMID 17667790 DOI: 10.1097/Ftd.0B013E318074D979 |
0.382 |
|
| 2007 |
Acosta EP, Brundage RC, King JR, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud G, Whitley R, Kimberlin DW. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clinical Pharmacology and Therapeutics. 81: 867-72. PMID 17392728 DOI: 10.1038/Sj.Clpt.6100150 |
0.35 |
|
| 2007 |
Balfour HH, Hokanson KM, Schacherer RM, Fietzer CM, Schmeling DO, Holman CJ, Vezina HE, Brundage RC. A virologic pilot study of valacyclovir in infectious mononucleosis. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 39: 16-21. PMID 17369082 DOI: 10.1016/J.Jcv.2007.02.002 |
0.725 |
|
| 2007 |
Saitoh A, Fletcher CV, Brundage R, Alvero C, Fenton T, Hsia K, Spector SA. Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 280-5. PMID 17356468 DOI: 10.1097/Qai.0B013E318040B29E |
0.32 |
|
| 2007 |
Weller DR, Brundage RC, Balfour HH, Vezina HE. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 848: 369-73. PMID 17081812 DOI: 10.1016/J.Jchromb.2006.10.022 |
0.726 |
|
| 2007 |
Kaila N, Straka RJ, Brundage RC. Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype. Journal of Pharmacokinetics and Pharmacodynamics. 34: 141-56. PMID 17053980 DOI: 10.1007/S10928-006-9038-9 |
0.705 |
|
| 2006 |
Kirstein MN, Brundage RC, Elmquist WF, Remmel RP, Marker PH, Guire DE, Yee D. Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens. Breast Cancer Research and Treatment. 96: 217-25. PMID 16502018 DOI: 10.1007/S10549-005-9004-Z |
0.303 |
|
| 2006 |
Vezina HE, Henry K, Ravindran GD, Kurpad AV, Raj TD, Fox K, Weller D, Brundage RC, Cavert W, Balfour HH. A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 131-6. PMID 16394842 DOI: 10.1097/01.Qai.0000199098.95967.Ab |
0.748 |
|
| 2006 |
MARINO S, CLOYD J, BRUNDAGE R, BIRNBAUM A, CONWAY J, MUSIB L, RAMSAY R, PENNELL P, WHITE J, LEPPIK I. PII-65Carbamazepine pharmacokinetics following simultaneous administration of an oral dose and a stable-labeled injection Clinical Pharmacology & Therapeutics. 79: P53-P53. DOI: 10.1016/J.Clpt.2005.12.190 |
0.33 |
|
| 2005 |
Ahn JE, Birnbaum AK, Brundage RC. Inherent correlation between dose and clearance in therapeutic drug monitoring settings: possible misinterpretation in population pharmacokinetic analyses. Journal of Pharmacokinetics and Pharmacodynamics. 32: 703-18. PMID 16328100 DOI: 10.1007/S10928-005-0083-6 |
0.705 |
|
| 2005 |
Fletcher CV, Testa MA, Brundage RC, Chesney MA, Haubrich R, Acosta EP, Martinez A, Jiang H, Gulick RM. Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 301-6. PMID 16249704 DOI: 10.1097/01.Qai.0000180078.53321.6A |
0.327 |
|
| 2005 |
Balfour HH, Holman CJ, Hokanson KM, Lelonek MM, Giesbrecht JE, White DR, Schmeling DO, Webb CH, Cavert W, Wang DH, Brundage RC. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. The Journal of Infectious Diseases. 192: 1505-12. PMID 16206064 DOI: 10.1086/491740 |
0.336 |
|
| 2004 |
King JR, Wynn H, Brundage R, Acosta EP. Pharmacokinetic enhancement of protease inhibitor therapy. Clinical Pharmacokinetics. 43: 291-310. PMID 15080763 DOI: 10.2165/00003088-200443050-00003 |
0.38 |
|
| 2004 |
Fletcher CV, Jiang H, Brundage RC, Acosta EP, Haubrich R, Katzenstein D, Gulick RM. Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359. The Journal of Infectious Diseases. 189: 1176-84. PMID 15031785 DOI: 10.1086/382754 |
0.321 |
|
| 2004 |
Brundage RC, Yong FH, Fenton T, Spector SA, Starr SE, Fletcher CV. Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy. Antimicrobial Agents and Chemotherapy. 48: 979-84. PMID 14982792 DOI: 10.1128/Aac.48.3.979-984.2004 |
0.368 |
|
| 2003 |
Jacobson PA, Ng J, Green KGE, Rogosheske J, Brundage R. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation. 9: 304-311. PMID 12766880 DOI: 10.1016/S1083-8791(03)00076-4 |
0.409 |
|
| 2002 |
Starr SE, Fletcher CV, Spector SA, Brundage RC, Yong FH, Douglas SD, Flynn PM, Kline MW. Efavirenz liquid formulation in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 21: 659-63. PMID 12237599 DOI: 10.1097/00006454-200207000-00011 |
0.354 |
|
| 2002 |
Wynn HE, Brundage RC, Fletcher CV. Clinical implications of CNS penetration of antiretroviral drugs. Cns Drugs. 16: 595-609. PMID 12153332 DOI: 10.2165/00023210-200216090-00002 |
0.344 |
|
| 2002 |
Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K. Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection. Clinical Pharmacology and Therapeutics. 71: 122-30. PMID 11907486 DOI: 10.1067/Mcp.2002.121423 |
0.382 |
|
| 2001 |
Jacobson P, Ng J, Ratanatharathorn V, Uberti J, Brundage RC. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients Bone Marrow Transplantation. 28: 753-758. PMID 11781626 DOI: 10.1038/Sj.Bmt.1703224 |
0.406 |
|
| 2001 |
Kakuda TN, Page LM, Anderson PL, Henry K, Schacker TW, Rhame FS, Acosta EP, Brundage RC, Fletcher CV. Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir Antimicrobial Agents and Chemotherapy. 45: 236-242. PMID 11120972 DOI: 10.1128/Aac.45.1.236-242.2001 |
0.361 |
|
| 2000 |
Anderson PL, Brundage RC, Bushman L, Kakuda TN, Remmel RP, Fletcher CV. Indinavir plasma protein binding in HIV-1-infected adults Aids. 14: 2293-2297. PMID 11089617 DOI: 10.1097/00002030-200010200-00010 |
0.348 |
|
| 2000 |
Fletcher CV, Kawle SP, Kakuda TN, Anderson PL, Weller D, Bushman LR, Brundage RC, Remmel RP. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons Aids. 14: 2137-2144. PMID 11061655 DOI: 10.1097/00002030-200009290-00010 |
0.346 |
|
| 2000 |
Acosta EP, Kakuda TN, Brundage RC, Anderson PL, Fletcher CV. Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors Clinical Infectious Diseases. 30. PMID 10860900 DOI: 10.1086/313852 |
0.367 |
|
| 2000 |
Fletcher CV, Brundage RC, Remmel RP, Page LM, Weller D, Calles NR, Simon C, Kline MW. Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy. Antimicrobial Agents and Chemotherapy. 44: 1029-34. PMID 10722507 DOI: 10.1128/Aac.44.4.1029-1034.2000 |
0.371 |
|
| 1999 |
Fletcher CV, Kakuda TN, Page LM, Acosta EP, Brundage RC, Anderson PL, Henry K, Schacker T. Pharmacokinetic strategies for concentration-targeted therapy with zidovudine (ZDV), lamivudine (3TC), and indinavir (IDV) Clinical Pharmacology and Therapeutics. 65: 161. DOI: 10.1016/S0009-9236(99)80174-X |
0.361 |
|
| 1998 |
Graves NM, Brundage RC, Wen Y, Cascino G, So E, Ahman P, Rarick J, Krause S, Leppik IE. Population pharmacokinetics of carbamazepine in adults with epilepsy Pharmacotherapy. 18: 273-281. PMID 9545146 DOI: 10.1002/J.1875-9114.1998.Tb03853.X |
0.353 |
|
| 1995 |
Shah AK, Brundage RC, Lake KD, Sawchuk RJ. The estimation of the plasma free fraction of cyclosporine in rabbits and heart transplant patients: the application of a physiological model of renal clearance. Biopharmaceutics & Drug Disposition. 16: 59-70. PMID 7711283 DOI: 10.1002/Bdd.2510160106 |
0.329 |
|
| 1994 |
Seay RE, Brundage RC, Jensen PD, Schilling CG, Edgren BE. Population pharmacokinetics of vancomycin in neonates Clinical Pharmacology and Therapeutics. 56: 169-175. PMID 8062493 DOI: 10.1038/Clpt.1994.120 |
0.362 |
|
| 1992 |
Jensen PD, Edgren BE, Brundage RC. Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model Pharmacotherapy. 12: 178-182. PMID 1608849 DOI: 10.1002/J.1875-9114.1992.Tb04506.X |
0.362 |
|
| 1992 |
Shah AK, Brundage RC, Gratwohl A, Sawchuk RJ. Pharmacokinetic model for subcutaneous absorption of cyclosporine in the rabbit during chronic treatment Journal of Pharmaceutical Sciences. 81: 491-495. PMID 1522483 DOI: 10.1002/Jps.2600810602 |
0.362 |
|
| 1991 |
Wiest DB, Pinson JB, Gal PS, Brundage RC, Schall S, Ransom JL, Weaver RL, Purohit D, Brown Y. Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus Clinical Pharmacology and Therapeutics. 49: 550-557. PMID 2029829 DOI: 10.1038/Clpt.1991.65 |
0.332 |
|
| Show low-probability matches. |